1. A Peroxisome Proliferator-Activated Receptor-gamma Agonist and Other Constituents fromChromolaena odorata
- Author
-
Kyeong Lee, Jung Joon Lee, Young Ho Kim, Chau Van Minh, Nguyen Tien Dat, and Young-Soo Hong
- Subjects
Agonist ,medicine.drug_class ,Chromolaena odorata ,Pharmaceutical Science ,Peroxisome proliferator-activated receptor ,Pharmacognosy ,Analytical Chemistry ,Rosiglitazone ,Chromolaena ,Drug Discovery ,medicine ,Humans ,Hypoglycemic Agents ,Receptor ,Flavonoids ,Pharmacology ,chemistry.chemical_classification ,biology ,Plant Extracts ,Organic Chemistry ,Peroxisome ,biology.organism_classification ,PPAR gamma ,Complementary and alternative medicine ,Nuclear receptor ,Biochemistry ,chemistry ,Fatty Acids, Unsaturated ,Prostaglandins ,Molecular Medicine ,Thiazolidinediones ,lipids (amino acids, peptides, and proteins) - Abstract
Peroxisome proliferator-activated receptors (PPARs) are key regulators of lipid and glucose metabolism and have become important therapeutic targets for various diseases. The phytochemical investigation of the chloroform-soluble extract of Chromolaena odorata led to the isolation of a PPAR-gamma agonist, (9 S,13 R)-12-oxo-phytodienoic acid (1), together with 12 other compounds. The structures of chromomoric acid G (2), a new dehydrogenated derivative of 1, and chromolanone (3) were elucidated based on spectroscopic methods. Compound 1 showed a significant effect on PPAR-gamma activation in comparison with rosiglitazone. However, compound 2 was inactive, suggesting that the dehydrogenation of the prostaglandin-like structure in 1 abrogates its PPAR-gamma agonistic activity.
- Published
- 2009
- Full Text
- View/download PDF